Oral magnesium supplements for cancer treatment‐induced hypomagnesemia: Results from a pilot randomized trial

BACKGROUND AND AIMS: Optimal management of cancer treatment‐induced hypomagnesemia (hMg) is not known. We assessed the feasibility of using a novel pragmatic clinical trials model to compare two commonly used oral Mg replacement strategies. METHODS: Patients with grade 1 to 3 hMg while receiving eit...

Descripción completa

Detalles Bibliográficos
Autores principales: Awan, Arif, Basulaiman, Bassam, Stober, Carol, Clemons, Mark, Fergusson, Dean, Hilton, John, Al Ghareeb, Waleed, Goodwin, Rachel, Ibrahim, Mohammed, Hutton, Brian, Vandermeer, Lisa, Mallick, Ranjeeta, Vickers, Michael M.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: John Wiley and Sons Inc. 2021
Materias:
Research Articles
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8669698/
https://www.ncbi.nlm.nih.gov/pubmed/34938893
http://dx.doi.org/10.1002/hsr2.443

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8669698/
https://www.ncbi.nlm.nih.gov/pubmed/34938893
http://dx.doi.org/10.1002/hsr2.443

Ejemplares similares